Colgate-Palmolive reported an 8.4% increase in revenue for Q1, driven by strong performance outside North America. However, its North American segment saw a 28% decline in operating profit due to tariffs and freight cost pressures. The company is expanding its SGPP productivity program, aiming to save $200 million to $300 million annually by 2028 through supply chain and operational improvements. Despite solid cash flow and manageable debt, Colgate-Palmolive's stock trades at a high forward P/E ratio above 23, leading analysts to maintain a hold rating until profitability improves further.
The New York Stock Exchange (NYSE) issued its daily pre-market update on June 8, 2026, delivering insights directly from the trading floor. Equities opened higher despite ongoing Middle East tensions. Highlights include AstraZeneca's recent NYSE tran...
This monthly series highlights five large-cap, dividend-paying stocks trading at significant discounts compared to their historical norms, selected from over 7,500 U.S.-listed companies. The primary list offers an average yield of 4.2%, with two addi...
